verified SJR 0,707 · Q2 • database Scopus / SJR & Web of Science indexed

Switzerland · S. Karger AG

workspace_premium Q2 — Oncology lock Subscription Unclaimed

Breast Care

Breast Care is a journal indexed in SJR in Oncology and Surgery with an H index of 47. It has an SJR impact factor of 0,707 and it has a best quartile of Q2. It has an SJR impact factor of 0,707.

Breast Care focuses its scope in these topics and keywords: breast, cancer, therapy, neoadjuvant, german, msp, exercise, patients, evidence, clinical, ...

ISSN: 1661-3791

Editorial: S. Karger AG

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

0,707 Q2

H-index 47

Tasa de Aceptación pie_chart

34%

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

NPD

Campo Sin dato

Coste de Publicación (APC) payments

NPD Subscription

Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

0,707

H-index

Docs (year)

Docs 3y

230

Total refs

1099

Cites 3y

466

Citable 3y

204

Cites/Doc 2y

1.83

Ref/Doc

29.7

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Presence of Basement Membrane Material around the Tubules of Tubulolobular Carcinoma

Trastuzumab, Pertuzumab, and Docetaxel as the First Line for HER-2-Positive Metastatic Breast Cancer among Arabs

Three Metachronous Cases of HER2-Positive Breast Cancer Accompanied with Thyroid Cancer

Tumor Cell Dissemination and Metastasis in Breast Cancer: Selected Presentations at the 28th San Antonio Breast Cancer Symposium 2005

Tumor Bed Boost Integration during Whole Breast Radiotherapy: A Review of the Current Evidence

Trastuzumab for Early Breast Cancer: Hope or Hype?

Trastuzumab as Intellectual, Medical and Economical Challenge

Trastuzumab (Herceptin¬Æ): Monoclonal Antibody in the Treatment of HER2/neu-Overexpressing Breast Cancer in the Metastatic and (Neo)adjuvant Situation

Trastuzumab Improves the Efficacy of Chemotherapy in Breast Cancer Treatment beyond Progression

San Antonio Report 2005: Diagnostics, Detection, Proteomics, Nanotechnology, Pathology, Operative Techniques

Quality of Life after Autologous Peripheral Blood Stem Cell Transplantation and High-Dose Chemotherapy in High-Risk Breast Cancer Patients

Protroca: A Noninterventional Study on Prophylactic Lipegfilgrastim against Chemotherapy-Induced Neutropenia in Nonselected Breast Cancer Patients

SHOW MORE ARTICLES

Strahlentherapie beim Mammakarzinom

Pregnancy-Associated Breast Cancer: Clinicopathological Characteristics of 20 Cases with a Focus on Identifiable Causes of Diagnostic Delay

Predictive and Prognostic Markers in Breast Cancer Treatment -Presentations at the 28th San Antonio Breast Cancer Symposium 2005

Physical Activity, Exercise and Breast Cancer - What Is the Evidence for Rehabilitation, Aftercare, and Survival? A Review

Peptide Receptor Radionuclide Therapy (PRRT) in a Patient Affected by Metastatic Breast Cancer with Neuroendocrine Differentiation

Patients' Perspective on Day Case Breast Surgery

Nutritive Supplements -Help or Harm for Breast Cancer Patients?

Modell eines Mammakarzinom-Netzwerkes: <<Brustzentrum Regio>>

Metastatic Breast Carcinoma Presenting as Perforated Appendicitis

Local Breast Cancer Recurrence after Mastectomy and Breast-Conserving Surgery for Paget's Disease: A Meta-Analysis

Lipocalin-1 Expression as a Prognosticator Marker of Survival in Breast Cancer Patients

Kleine Wissenschaft vom Mann

FAQS

In Country of Papers you can find SJR impact factor and other metrics to help you decide on a Journal.